In vivo evaluation of the uptake of [123I]FIAU, [123I]IVFRU and [123I]IVFAU by normal mouse brain:: Potential for noninvasive assessment of HSV-1 thymidine kinase gene expression in gliomas

被引:5
|
作者
Li, H. -F. [1 ]
Winkeler, A. [1 ,2 ,3 ]
Moharram, S. [4 ]
Knaus, E. E. [4 ]
Dittmar, K. [1 ,2 ,3 ]
Stoeckle, M. [1 ]
Heiss, W. D. [2 ,3 ]
Wiebe, L. I. [4 ]
Jacob, A. J. [2 ,3 ]
机构
[1] Univ Cologne, MPI Neurol Res, Dept Neurol, PET Lab, D-50931 Cologne, Germany
[2] Univ Cologne, Fac Med, Cologne, Germany
[3] Univ Cologne, Ctr Mol Med, Cologne, Germany
[4] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
来源
关键词
blood-brain barrier (BBB); gene expression; brain permeability; herpes simplex virus type 1 thymidine kinase (HSV-1-TK);
D O I
10.1080/15257770701571933
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Radioiodinated 5-iodo-1-(2-fluoro-2-deoxy--D-arabinofuranosyl)uracil (F *IAU) is most commonly used for noninvasive assessment of herpes simplex virus type 1 thymidine kinase (HSV-1-tk) gene expression. However, it does not permeate the intact blood-brain barrier (BBB) because of its moderate lipophilicity. In this work, three iodo-nucleosides, FIAU, IVFRU, and IVFAU, were radiolabeled with iodine-123 and tested for permeation of the BBB in mice and for potential measurement of HSV-1-tk gene expression in gliomas. The results demonstrate that brain uptake and retention of these nucleosides is not directly related to their lipophilicity. The low brain uptake of IVFAU, in conjunction with its higher and constant brain/blood ratio, may reflect greater stability against hydrolysis of the N-glycosidic bond. In vivo PET evaluations of [124I]IVFRU and [124I]IVFAU in tumor-bearing mice are warranted.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 50 条
  • [1] In vivo evaluation of the uptake of [123I]FIAU, [123I]IVFRU, and [123I]IVFAU by normal mouse brain:: Potential for noninvasive assessment of HSV-1 thymidine kinase gene expression in gliomas (vol 27, pg 57, 2008)
    Li, H. -F.
    Winkeler, A.
    Moharram, S.
    Knaus, E. E.
    Dittmar, K.
    Stoeckle, M.
    Heiss, W. D.
    Wiebe, L. I.
    Jacobs, A. H.
    [J]. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2008, 27 (08): : 1009 - 1009
  • [2] In vivo evaluation of [123I]IVFRU and [123I]IVFAU in rats for potential non-invasive assessment of HSV-1 thymidine kinase gene expression in gliomas
    Li, HF
    Winkler, A
    Moharram, S
    Knaus, EE
    Heiss, WD
    Wiebe, LI
    Jacobs, AH
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S395 - S396
  • [3] SPECT imaging of herpes simplex virus type1 thymidine kinase gene expression by [123I]FIAU
    Choi, SR
    Zhuang, ZP
    Chacko, AM
    Acton, PD
    Tjuvajev-Gelovani, J
    Doubrovin, M
    Chu, DCK
    Kung, HF
    [J]. ACADEMIC RADIOLOGY, 2005, 12 (07) : 798 - 805
  • [4] Comparison of in vivo dopamine D2 receptor binding of [123I]AIBZM and [123I]IBZM in rat brain
    Li, HF
    Gildehaus, FJ
    Dresel, S
    Patt, JT
    Shen, MH
    Zhu, T
    Liu, BL
    Tang, ZG
    Tatsch, K
    Hahn, K
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (04) : 383 - 389
  • [5] Evaluation of tumor affinity of mono-[123I]iodohypericin and mono-[123I]iodoprotohypericin in a mouse model with a RIF-1 tumor
    Fonge, Humphrey
    Van de Putte, Marie
    Huyghe, Dieter
    Bormans, Guy
    Ni, Yicheng
    de Witte, Peter
    Verbruggen, Alfons
    [J]. CONTRAST MEDIA & MOLECULAR IMAGING, 2007, 2 (03) : 113 - 119
  • [6] Investigation of the Radiolabelling Potential of the Aurora A Kinase Inhibitor Alisertib with Iodine-123 [123I]
    Uygur, E.
    Sezgin, C.
    Akdag, B. Y.
    Ozbey, T.
    Parlak, Y.
    Karatay, K. B.
    Gumuser, F. G.
    Muftuler, F. Z. Biber
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S782 - S782
  • [7] Synthesis and in Vivo Evaluation of [123I]Melanin-Targeted Agents
    Roberts, Maxine P.
    Nguyen, Vu
    Ashford, Mark E.
    Berghofer, Paula
    Wyatt, Naomi A.
    Krause-Heuer, Anwen M.
    Pham, Tien Q.
    Taylor, Stephen R.
    Hogan, Leena
    Jiang, Cathy D.
    Fraser, Benjamin H.
    Lengkeek, Nigel A.
    Matesic, Lidia
    Gregoire, Marie-Claude
    Denoyer, Delphine
    Hicks, Rodney J.
    Katsifis, Andrew
    Greguric, Ivan
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (15) : 6214 - 6224
  • [8] In vivo evaluation of [123I]mZIENT as a SPECT radioligand for the serotonin transporter
    Batis, Jeffery
    Barret, Olivier
    Alagille, David
    Koren, Andrei O.
    Stehouwer, Jeffrey S.
    Cosgrove, Kelly
    Goodman, Mark
    Seibyl, John
    Tamagnan, Gilles
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (08) : 1137 - 1141
  • [9] SYNTHESIS AND BIOLOGICAL EVALUATION OF [123I]QUINONOIDS FOR BRAIN TUMOR IMAGING
    Park, J. H.
    Kim, S. W.
    Lee, H. J.
    Yang, S. D.
    Chun, K. S.
    Yu, K. H.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S304 - S304
  • [10] [123I]-Vascular Endothelial Growth Factor in the evaluation of Brain Tumors
    Rainer, Eva
    Widhalm, Georg
    Marosi, Christine
    Haug, Alexander
    Hacker, Marcus
    Li, Shuren
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59